Elidel, Protopic “Black Box” Could Be Test Of FDA’s Labeling Authority

FDA's proposal to add a "black box" to labeling of the eczema treatments Elidel and Protopic could be a high-profile test of the agency's ability to change product labeling following recent congressional discussion of the agency's authority